BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23616623)

  • 21. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S; Schibler J; Gasilina A; Shrestha M; Lin S; Link KA; Chen J; Whitman SP; Bloomfield CD; Nicolet D; Assi SA; Ptasinska A; Heidenreich O; Bonifer C; Kitamura T; Nassar NN; Mulloy JC
    Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Ma L; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.
    Li Y; Wang H; Wang X; Jin W; Tan Y; Fang H; Chen S; Chen Z; Wang K
    Blood; 2016 Jan; 127(2):233-42. PubMed ID: 26546158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
    Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
    Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
    Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
    PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling.
    Stoner SA; Liu KTH; Andrews ET; Liu M; Arimoto KI; Yan M; Davis AG; Weng S; Dow M; Xian S; DeKelver RC; Carter H; Zhang DE
    Blood Cancer J; 2020 Feb; 10(2):16. PubMed ID: 32029705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death.
    Ding C; Chen SN; Macleod RAF; Drexler HG; Nagel S; Wu DP; Sun AN; Dai HP
    Ups J Med Sci; 2018 Mar; 123(1):19-27. PubMed ID: 29493383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia.
    Larizza L; Magnani I; Beghini A
    Leuk Lymphoma; 2005 Feb; 46(2):247-55. PubMed ID: 15621809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.
    Tonks A; Pearn L; Musson M; Gilkes A; Mills KI; Burnett AK; Darley RL
    Leukemia; 2007 Dec; 21(12):2495-505. PubMed ID: 17898786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
    Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 34. RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells.
    Migas AA; Mishkova OA; Ramanouskaya TV; Ilyushonak IM; Aleinikova OV; Grinev VV
    Leuk Res; 2014 Sep; 38(9):1102-10. PubMed ID: 24976338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
    Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10398-403. PubMed ID: 11526243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of Pax5 target genes in early B cell differentiation.
    Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
    J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
    Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
    PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
    Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
    J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.